查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2096664

血管成形術用氣球市場－2026-2032年全球市場預測

Angioplasty Balloons Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血管成形術用氣球市場將成長至 37.8 億美元，複合年成長率為 5.24%。

主要市場統計數據
基準年 2025 26.4億美元
預計年份：2026年 27.7億美元
預測年份 2032 37.8億美元
複合年成長率 (%) 5.24%

血管成形術用氣球在經皮冠狀動脈腔內成形術 (PTCA) 和周邊血管介入治療中發揮核心作用，使臨床醫生能夠擴張狹窄或阻塞的血管，最佳化病變準備，並恢復冠狀動脈疾病、周邊動脈疾病和其他血管狹窄患者的血流。全球心血管疾病負擔沉重、糖尿病和肥胖症盛行率不斷上升、人口老化以及微創血管內手術的日益普及，都推動了對血管成形球囊的需求。世界衛生組織 (WHO) 指出，心血管疾病仍然是全球首要死因，而糖尿病和高血壓持續增加冠狀動脈和周邊動脈併發症的風險。產品創新主要集中在藥物釋放型球囊、刻痕切割球囊、高壓非順應性球囊、用於複雜鈣化病變的專用球囊以及在彎曲解剖結構中改進的導管輸送技術。血管成形術用氣球的市場趨勢受臨床證據、保險報銷政策、監管審查、醫院採購標準以及醫生對能夠提高手術成功率並減少血管再阻塞、血管創傷和再次干預的器械的偏好所影響。

血管成形術用氣球趨勢發生了變革性變化

血管成形術用氣球的發展趨勢正在轉變，從傳統的血管擴張轉向針對特異性病變和以療效為導向的治療。藥物塗層球囊在某些冠狀動脈和周邊血管疾病中日益受到重視，因為它們可以在不植入永久性植入的情況下進行抗增殖治療，從而支持那些需要避免額外金屬層的治療策略。同時，諸如刮除球囊、切割球囊和超高壓球囊等特殊球囊擴大用於治療難治性、纖維化或鈣化病變，這些病變需要在支架植入前進行可控的斑塊消融，或作為無支架治療方案的一部分。醫療系統優先考慮縮短手術時間、減少住院時間、降低併發症和降低重組率，這推動了以可靠的臨床和真實世界證據為支撐的血管成形術用氣球裝置的應用。監管機構對藥物-器械複合物的安全性、生物相容性、塗層完整性、顆粒物釋放、滅菌有效性和長期療效的期望越來越高，而醫院也在加強基於價值的採購要求，將器械的選擇與安全性、效率和已證實的臨床結果聯繫起來。

人工智慧（AI）的累積影響

人工智慧 (AI)血管成形術用氣球的整個生態系統產生了累積影響。 AI 驅動的影像分析可利用血管攝影、血管斑塊血管造影術、光學相干血管造影術斷層光學同調斷層掃描(CTA) 和電子健康記錄數據，輔助評估病灶長度、血管直徑、斑塊形態、鈣化負荷和解剖複雜性。這些功能有助於醫生在球囊類型、直徑、長度、充氣策略和輔助性治療做出更一致的選擇，尤其是在複雜的冠狀動脈和周邊血管介入治療中。在製造和品管系統中，AI 可增強製程監控、缺陷檢測、塗層均勻性評估和預測性維護，從而支援符合嚴格的醫療設備標準。在臨床實務中，機器學習可用於改善患者風險分層、識別血管再阻塞風險模式，並有助於產生基於註冊研究的證據。然而，要實現人工智慧，需要檢驗的演算法、透明的臨床決策支援、網路安全措施、與醫院系統的互通性、減少偏見以及監管途徑，以確保人工智慧工具是安全的、可解釋的和具有臨床意義的。

主要區域洞察

在亞太地區，血管成形術用氣球主要受心血管疾病高發生率、介入性心臟病學能力不斷提升、醫院基礎設施快速發展以及大都會圈導管檢查室普及等因素驅動。中國、印度、日本、韓國和澳洲是主要需求中心。在北美，該手術的應用已較為成熟，擁有完善的醫保報銷系統、成熟的複雜血管內治療技術以及對臨床指南的嚴格遵循。醫療設備的選擇通常受實證醫學證據、醫院價值分析和上市後安全監測的影響。在歐洲，其優勢包括系統的法律規範、強大的臨床研究網路以及微創心血管治療的廣泛應用，但醫療設備的採購也受到醫療技術評估、成本控制和臨床結果記錄的影響。拉丁美洲的特徵是心血管和周邊血管介入治療的需求不斷成長，公立和私立醫療系統之間存在服務取得方面的差異，以及對專科培訓和血管中心（尤其是巴西和墨西哥）的投資不斷增加。在非洲，由於導管介入基礎設施有限、勞動力短缺和費用高昂，獲得先進的心血管介入治療更為困難；然而，隨著都市區轉診醫院的建立以及公共和私人投資的增加，這種情況正在逐步改善。在中東，透過對三級醫療機構、醫療旅遊計畫和專科介入心臟病學中心的投資，介入治療能力正在不斷提升，這一趨勢在高所得海灣國家的醫療保健系統中尤為明顯，這些國家的糖尿病、肥胖症和高血壓是嚴重的公共衛生挑戰。

關鍵群體特定見解

北約成員國與多個心血管先進市場重疊，並高度重視具有韌性的醫療供應鏈、醫療設備安全性和醫療體系的準備。在當前地緣政治動盪和醫療技術供應鏈風險管理的背景下，這些因素的重要性日益凸顯。七國集團（G7）擁有成熟且高標準的醫療體系，血管成形術用氣球的使用主要受臨床證據、醫生專業知識、監管、上市後監測和基於價值的採購等因素驅動。金磚國家（BRICS）擁有大規模的患者群體，手術量不斷成長，國內醫療體係也在不斷現代化，但市場准入受到價格敏感性、當地生產政策、報銷機制差異以及專科醫療服務區域差異的影響。歐盟（EU）提供了一個高度監管且以證據為基礎的環境，醫療設備法規、上市後臨床追蹤、醫療技術評估和公共採購政策都會影響血管成形術用氣球的推廣應用。東南亞國協對血管成形術用氣球的需求成長主要受以下因素驅動：醫療保健覆蓋範圍擴大、糖尿病和高血壓盛行率上升，以及主要經濟體對心臟導管介入服務投入增加。然而，報銷機制的多樣性和專家的可近性仍然是影響其應用的重要因素。在海灣合作理事會（GCC）國家，由於該地區心血管代謝疾病負擔沉重，介入性心臟病學和血管護理正透過資金充足的醫院系統、國家醫療保健改革計劃以及積極應用先進醫療技術得到加強。

主要國家的概況

在中國，先進的心血管和周邊血管介入治療能力正在迅速發展，這得益於醫院現代化、國產醫療設備的研發、集中採購改革以及大量冠心病、糖尿病患者和人口老化。美國血管成形術用氣球、導管檢查室網路發達、醫保報銷機製完善以及積極開展冠狀動脈和周邊血管介入治療，仍然是血管成形球囊的主要中心。日本的先進臨床技術應用、人口老化以及精準的血管內治療技術正在推動這一發展，而印度則受到冠心病和糖尿病患者增多以及都市區醫院擴張的推動，儘管價格敏感性和主要城市以外地區的醫療服務可及性仍然是重大挑戰。德國是歐洲心臟介入治療中心，擁有強大的外科手術能力、專家團隊和完善的醫院基礎設施。同時，英國透過全國性的臨床指南、集中採購系統以及對治療效果和成本效益的高度重視，強調實證醫學的醫療設備選擇。澳洲受惠於高度專業化的醫療服務、高品質的註冊登記系統和完善的報銷機制；法國則在強而有力的監管和報銷體系下，維持著先進的心血管醫療服務。韓國兼具先進的醫院基礎設施、強大的臨床實力以及微創心血管技術的快速應用。義大利和西班牙擁有成熟的介入治療實踐，其公共醫療體系預算嚴格，且醫療資源在不同地區有所差異。在加拿大，全民健保、本地化的心臟醫療保健體係以及循證技術評估的支持下，手術需求強勁，但各省的醫療資源獲取情況可能有所不同。在俄羅斯，需求與心血管疾病的盛行率及其廣泛的地域密切相關，醫療服務的可近性取決於當地醫療基礎設施和供應鏈的狀況。巴西擁有拉丁美洲最大的介入心臟病學基地之一，這得益於其主要的都市區心臟中心以及糖尿病、高血壓和周邊動脈疾病盛行率的不斷上升。同時，在墨西哥，隨著私部門的發展和公立醫院的現代化，介入性心臟病學的普及程度正在提高，但成本效益和報銷方案仍然是重要的考慮因素。

為行業領導者提供的實用建議

產業領導者應優先考慮以實證醫學為基礎的創新，以解決複雜病變、預防血管再阻塞、提高輸送效率、手術效率和改善患者長期預後等問題。研發策略應包括嚴謹的臨床試驗設計、真實世界證據 (RWE) 項目以及針對藥物塗層球囊、特種球囊和新一代導管平台的上市後監測。製造商應提高塗層一致性、球囊順應性管理、透過曲線最佳化、可追溯性和爆破壓力可靠性，同時使品管系統符合全球監管要求。銷售團隊應根據當地的健保報銷方案、醫院採購和醫生培訓需求，制定相應的打入市場策略，尤其是在介入治療基礎設施不斷擴展的地區。與醫院、學術研究人員和數位醫療開發商夥伴關係，可以支援手術培訓、人工智慧驅動的影像整合以及基於註冊登記的療效追蹤。應透過採購管道多元化、冗餘的檢驗生產系統以及對聚合物、塗層、導管導引線相容組件、造影劑相容材料和滅菌能力進行主動風險監測，來提高供應鏈的韌性。此外，經營團隊於醫師教育，使其了解針對不同病灶選擇合適的球囊、尺寸、充氣方案和安全使用方法，特別是藥物塗層球囊、球囊導管、切割球囊和高壓血管成形術用氣球。

調查方法

本執行摘要採用系統的二手研究方法檢驗，使用了經驗證的公共領域和行業相關資訊來源，包括監管指南、臨床實踐指南、同行評審的醫學文獻、疾病負擔出版物、醫院採購趨勢、衛生技術評估 (HTA) 參考資料以及醫療設備安全資訊。研究途徑調查方法強調對臨床、監管、程序和宏觀健康指標進行檢驗，以識別影響血管成形術用氣球應用的實證模式。透過醫療基礎設施成熟度、心血管疾病盛行率、報銷環境、導管檢查室的可及性、專家資源、監管要求以及微創血管介入治療的既有趨勢，評估了區域、群體和國家層面的具體情況。本分析不涉及市場規模、市場佔有率、收入估算和預測，而是著重於定性和資料支援的促進因素、障礙、創新趨勢和策略意義。

結論

血管成形術用氣球仍然是現代冠狀動脈和周邊血管介入治療中一項至關重要的技術，其重要性持續受到心血管疾病負擔、微創治療普及以及對改善病變特異性治療效果的需求的限制。在臨床實踐中，隨著循證醫學證據的增強、監管合規性的提高以及對真實臨床環境中治療結果的追蹤，藥物塗層、專用和高性能球囊平台正逐漸被應用。人工智慧、先進影像技術和數位化臨床工作流程正在改善手術計劃和術後監測，但區域推廣仍依賴保險報銷、基礎設施、臨床醫生的專業水平、經濟承受能力和供應穩定性。將臨床驗證的創新技術、穩健的供應鏈、醫生教育和區域准入策略相結合的行業相關人員將更有能力支持更安全、更有效、更廣泛應用的血管成形術用氣球介入治療。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：血管成形術用氣球：依產品類型分類

  • 冠狀動脈成形術球囊
    • 標準（半相容）氣球
    • 不合規的氣球
    • 切割刮痕氣球
  • 血管成形術用氣球
    • 藥物塗層末梢用球囊
    • 高壓末梢用球囊
    • 特殊末梢用球囊
  • 神經血管球囊
    • 用於裝修的氣球
    • 閉塞球囊

第8章：血管成形術用氣球市場：依材料類型分類

  • 尼龍氣球
  • 聚氨酯氣球
  • 聚對苯二甲酸乙二醇酯氣球
  • Pebax氣球

第9章：血管成形術用氣球市場：依球囊直徑分類

  • 小型
  • 中等的
  • 大的

第10章：血管成形術用氣球市場：依銷售管道分類

  • 直銷
  • 分銷商和經銷商的銷售額
    • 大型經銷商網路
    • 獨立經銷商網路
  • 線上和電子採購

第11章：血管成形術用氣球市場：依最終用戶分類

  • 門診手術中心
  • 心臟中心
  • 醫院
  • 專科診所

第12章：血管成形術用氣球市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第13章：血管成形術用氣球市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第14章血管成形術用氣球市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Acrostak Int. Distr. Sarl
  • AngioDynamics, Inc.
  • Asahi Intecc Co., Ltd.
  • B. Braun SE
  • Balton Sp. z oo
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd.
  • Cardinal Health, Inc.
  • Concept Medical Inc.
  • Cook Group Incorporated
  • Cordis
  • ENDOCOR GmbH
  • Hexacath
  • InSitu Technologies Inc.
  • iVascular SLU
  • Kaneka Corporation
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • phenox GmbH
  • Scitech Medical
  • Teleflex Incorporated.
  • Terumo Medical Corporation
Product Code: MRR-957C47F90693

The Angioplasty Balloons Market is projected to grow by USD 3.78 billion at a CAGR of 5.24% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.64 billion
Estimated Year [2026] USD 2.77 billion
Forecast Year [2032] USD 3.78 billion
CAGR (%) 5.24%

Angioplasty balloons are central to percutaneous transluminal coronary angioplasty and peripheral vascular intervention, enabling clinicians to dilate narrowed or obstructed vessels, optimize lesion preparation, and restore blood flow in patients with coronary artery disease, peripheral artery disease, and other vascular stenoses. Demand is supported by the well-documented global cardiovascular disease burden, rising diabetes and obesity prevalence, population aging, and increased use of minimally invasive endovascular procedures. According to the World Health Organization, cardiovascular diseases remain the leading cause of death globally, while diabetes and hypertension continue to elevate risks for coronary and peripheral arterial complications. Product innovation is focused on drug-coated balloons, scoring and cutting balloons, high-pressure non-compliant balloons, specialty balloons for complex calcified lesions, and improved catheter deliverability for tortuous anatomy. The angioplasty balloon landscape is shaped by clinical evidence, reimbursement policies, regulatory scrutiny, hospital procurement standards, and physician preference for devices that improve procedural success while reducing restenosis, vessel trauma, and repeat intervention.

Transformative Shifts in the Angioplasty Balloon Landscape

The angioplasty balloon landscape is being reshaped by a shift from conventional vessel dilation toward lesion-specific and outcome-focused therapy. Drug-coated balloons have gained clinical relevance in selected coronary and peripheral indications because they deliver antiproliferative therapy without leaving a permanent implant, supporting treatment strategies where avoiding additional metal layers is preferred. At the same time, specialty balloons such as scoring, cutting, and ultra-high-pressure balloons are increasingly used for resistant, fibrotic, or calcified lesions that require controlled plaque modification before stenting or as part of a stent-free approach. Healthcare systems are prioritizing shorter procedure times, reduced hospitalization, fewer complications, and lower repeat revascularization rates, encouraging adoption of angioplasty balloon devices supported by robust clinical and real-world evidence. Regulatory expectations are rising around drug-device combination safety, biocompatibility, coating integrity, particulate release, sterilization validation, and long-term outcomes, while hospitals are strengthening value-based purchasing requirements that link device selection to safety, efficiency, and documented clinical performance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative impact across the angioplasty balloon ecosystem by improving diagnosis, procedural planning, device selection, workflow efficiency, and post-procedure surveillance. AI-enabled imaging analytics can support assessment of lesion length, vessel diameter, plaque morphology, calcium burden, and anatomical complexity using angiography, intravascular ultrasound, optical coherence tomography, computed tomography angiography, and electronic health record data. These capabilities can help physicians select balloon type, diameter, length, inflation strategy, and adjunctive therapy more consistently, particularly in complex coronary and peripheral interventions. In manufacturing and quality systems, AI can enhance process monitoring, defect detection, coating uniformity assessment, and predictive maintenance, supporting compliance with stringent medical device standards. In clinical operations, machine learning can improve patient risk stratification, identify restenosis risk patterns, and support registry-based evidence generation. However, adoption depends on validated algorithms, transparent clinical decision support, cybersecurity controls, interoperability with hospital systems, bias mitigation, and regulatory pathways that ensure AI tools are safe, explainable, and clinically meaningful.

Key Regional Insights

In Asia-Pacific, angioplasty balloon adoption is supported by high cardiovascular disease burden, expanding interventional cardiology capacity, rapid hospital infrastructure development, and growing access to catheterization laboratories in large urban centers, with China, India, Japan, South Korea, and Australia serving as major demand centers. North America demonstrates mature procedural adoption, advanced reimbursement frameworks, established use of complex endovascular techniques, and strong clinical guideline adherence, with device selection often shaped by evidence generation, hospital value analysis, and post-market safety surveillance. Europe benefits from structured regulatory oversight, strong clinical research networks, and widespread adoption of minimally invasive cardiovascular care, while procurement is influenced by health technology assessment, cost containment, and clinical outcome documentation. Latin America is characterized by rising need for cardiovascular and peripheral vascular interventions, uneven access between public and private healthcare systems, and increasing investment in specialist training and vascular centers, particularly in Brazil and Mexico. Africa faces higher access constraints due to limited catheterization infrastructure, workforce shortages, and affordability challenges, although urban referral hospitals and public-private investments are gradually improving availability of advanced cardiovascular interventions. The Middle East is expanding interventional capacity through tertiary care investment, medical tourism initiatives, and specialty cardiac centers, particularly across high-income Gulf healthcare systems where diabetes, obesity, and hypertension are prominent public health priorities.

Key Group Insights

NATO member countries overlap with several advanced cardiovascular markets and emphasize resilient medical supply chains, device safety, and healthcare system readiness, factors that have become more prominent amid geopolitical disruptions and medical technology supply chain risk management. G7 countries represent mature, high-standard healthcare systems where angioplasty balloon utilization is guided by clinical evidence, physician expertise, regulatory oversight, post-market surveillance, and value-based procurement. BRICS countries combine large patient populations with expanding procedure volumes and domestic healthcare modernization, but market access is shaped by price sensitivity, local manufacturing policies, reimbursement variation, and regional disparities in specialist care. The European Union presents a highly regulated and evidence-driven environment, where medical device regulation, post-market clinical follow-up, health technology assessment, and public procurement policies shape angioplasty balloon adoption. ASEAN demand for angioplasty balloons is influenced by expanding healthcare access, rising diabetes and hypertension prevalence, and increasing investment in cardiac catheterization services across major economies, although reimbursement diversity and specialist availability remain important adoption factors. GCC countries are strengthening interventional cardiology and vascular care through well-funded hospital systems, national health transformation programs, and high use of advanced medical technologies, supported by the region's significant cardiometabolic disease burden.

Key Country Insights

China is rapidly expanding advanced cardiovascular and peripheral vascular intervention capacity, supported by hospital modernization, domestic device development, centralized procurement reforms, and high patient volume linked to coronary artery disease, diabetes, and aging demographics. The United States remains a major center for angioplasty balloon use due to high cardiovascular disease prevalence, extensive catheterization laboratory networks, advanced reimbursement mechanisms, and strong adoption of coronary and peripheral interventions. Japan demonstrates high clinical sophistication, aging population dynamics, and strong adoption of precision endovascular techniques, while India is driven by rising coronary artery disease, diabetes, and urban hospital expansion, with price sensitivity and access outside major cities remaining central issues. Germany is a leading European hub for interventional cardiology, supported by high procedural capacity, specialist expertise, and broad hospital infrastructure, while the United Kingdom emphasizes evidence-based device selection through national clinical guidance, centralized procurement influences, and strong focus on outcomes and cost-effectiveness. Australia benefits from advanced specialist care, high-quality registries, and structured reimbursement, while France maintains advanced cardiovascular care delivery with strong regulatory and reimbursement oversight. South Korea combines advanced hospital infrastructure, strong clinical expertise, and rapid adoption of minimally invasive cardiovascular technologies, while Italy and Spain combine mature interventional practices with public health system budget discipline and regional procurement variation. Canada shows steady procedural demand supported by universal healthcare coverage, regionalized cardiac care systems, and evidence-based technology assessment, although access can vary by province and procedural capacity. Russia presents demand linked to cardiovascular disease burden and large geography, with access influenced by regional healthcare infrastructure and supply chain conditions. Brazil has one of Latin America's largest cardiovascular intervention bases, supported by major urban cardiac centers and a growing burden of diabetes, hypertension, and peripheral artery disease, while Mexico is expanding interventional cardiology access through private-sector growth and public hospital modernization, with affordability and reimbursement remaining key considerations.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-backed innovation that addresses complex lesions, restenosis prevention, deliverability, procedural efficiency, and long-term patient outcomes. Development strategies should include robust clinical study design, real-world evidence programs, and post-market surveillance for drug-coated balloons, specialty balloons, and next-generation catheter platforms. Manufacturers should strengthen coating consistency, balloon compliance control, crossing profile optimization, trackability, and burst-pressure reliability while aligning quality systems with global regulatory requirements. Commercial teams should tailor market access strategies to local reimbursement, hospital procurement, and physician training needs, especially in regions with expanding interventional infrastructure. Partnerships with hospitals, academic investigators, and digital health developers can support procedural education, AI-enabled imaging integration, and registry-based outcome tracking. Supply chain resilience should be improved through diversified sourcing, validated manufacturing redundancy, and proactive risk monitoring for polymers, coatings, guidewire-compatible components, contrast-compatible materials, and sterilization capacity. Leaders should also invest in physician education for lesion-specific balloon selection, sizing, inflation protocols, and safe use practices, particularly for drug-coated, scoring, cutting, and high-pressure angioplasty balloon technologies.

Research Methodology

This executive summary is developed through a structured secondary research approach using verified public-domain and industry-relevant sources, including regulatory guidance, clinical practice guidelines, peer-reviewed medical literature, disease burden publications, hospital procurement trends, health technology assessment references, and medical device safety communications. The methodology emphasizes triangulation of clinical, regulatory, procedural, and macro-healthcare indicators to identify evidence-based patterns affecting angioplasty balloon adoption. Regional, group, and country insights are assessed through healthcare infrastructure maturity, cardiovascular disease prevalence, reimbursement environment, catheterization laboratory access, specialist availability, regulatory requirements, and documented trends in minimally invasive vascular intervention. The analysis excludes market sizing, market share, revenue estimation, and forecasting, focusing instead on qualitative and data-backed drivers, barriers, innovation trends, and strategic implications.

Conclusion

Angioplasty balloons remain essential technologies in modern coronary and peripheral vascular intervention, with continued relevance driven by cardiovascular disease burden, minimally invasive treatment adoption, and demand for improved lesion-specific outcomes. The clinical landscape is moving toward drug-coated, specialty, and high-performance balloon platforms supported by stronger evidence, regulatory compliance, and real-world outcome tracking. Artificial intelligence, advanced imaging, and digital clinical workflows are strengthening procedural planning and post-procedure monitoring, while regional adoption continues to depend on reimbursement, infrastructure, clinician expertise, affordability, and supply continuity. Industry participants that combine clinically validated innovation, resilient supply chains, physician education, and region-specific access strategies will be better positioned to support safer, more effective, and more widely available angioplasty balloon interventions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Angioplasty Balloons Market, by Product Type

  • 7.1. Introduction
  • 7.2. Coronary Angioplasty Balloons
    • 7.2.1. Standard (Semi-Compliant) Balloons
    • 7.2.2. Non-Compliant Balloons
    • 7.2.3. Cutting and Scoring Balloons
  • 7.3. Peripheral Angioplasty Balloons
    • 7.3.1. Drug-Coated Peripheral Balloons
    • 7.3.2. High-Pressure Peripheral Balloons
    • 7.3.3. Specialty Peripheral Balloons
  • 7.4. Neurovascular Balloons
    • 7.4.1. Remodeling Balloons
    • 7.4.2. Occlusion Balloons

8. Angioplasty Balloons Market, by Material Type

  • 8.1. Introduction
  • 8.2. Nylon Balloons
  • 8.3. Polyurethane Balloons
  • 8.4. Polyethylene Terephthalate Balloons
  • 8.5. Pebax Balloons

9. Angioplasty Balloons Market, by Balloon Diameter

  • 9.1. Introduction
  • 9.2. Small
  • 9.3. Medium
  • 9.4. Large

10. Angioplasty Balloons Market, by Sales Channel

  • 10.1. Introduction
  • 10.2. Direct Sales
  • 10.3. Distributor and Dealer Sales
    • 10.3.1. Large-Scale Distributor Networks
    • 10.3.2. Independent Dealer Networks
  • 10.4. Online and E-Procurement

11. Angioplasty Balloons Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Cardiac Centers
  • 11.4. Hospitals
  • 11.5. Specialty Clinics

12. Angioplasty Balloons Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. Europe
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Africa
  • 12.6. Middle East

13. Angioplasty Balloons Market, by Group

  • 13.1. NATO
  • 13.2. G7
  • 13.3. BRICS
  • 13.4. European Union
  • 13.5. ASEAN
  • 13.6. GCC

14. Angioplasty Balloons Market, by Country

  • 14.1. China
  • 14.2. United States
  • 14.3. Japan
  • 14.4. India
  • 14.5. Germany
  • 14.6. United Kingdom
  • 14.7. Australia
  • 14.8. France
  • 14.9. South Korea
  • 14.10. Italy
  • 14.11. Canada
  • 14.12. Russia
  • 14.13. Brazil
  • 14.14. Mexico
  • 14.15. Spain

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Acrostak Int. Distr. Sarl
  • 16.3. AngioDynamics, Inc.
  • 16.4. Asahi Intecc Co., Ltd.
  • 16.5. B. Braun SE
  • 16.6. Balton Sp. z o.o.
  • 16.7. Becton, Dickinson and Company
  • 16.8. BIOTRONIK SE & Co. KG
  • 16.9. Boston Scientific Corporation
  • 16.10. BrosMed Medical Co., Ltd.
  • 16.11. Cardinal Health, Inc.
  • 16.12. Concept Medical Inc.
  • 16.13. Cook Group Incorporated
  • 16.14. Cordis
  • 16.15. ENDOCOR GmbH
  • 16.16. Hexacath
  • 16.17. InSitu Technologies Inc.
  • 16.18. iVascular S.L.U.
  • 16.19. Kaneka Corporation
  • 16.20. Koninklijke Philips N.V
  • 16.21. Lepu Medical Technology(Beijing)Co., Ltd.
  • 16.22. Medtronic PLC
  • 16.23. Merit Medical Systems, Inc.
  • 16.24. MicroPort Scientific Corporation
  • 16.25. Nipro Medical Corporation
  • 16.26. phenox GmbH
  • 16.27. Scitech Medical
  • 16.28. Teleflex Incorporated.
  • 16.29. Terumo Medical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANGIOPLASTY BALLOONS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ANGIOPLASTY BALLOONS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ANGIOPLASTY BALLOONS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ANGIOPLASTY BALLOONS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL ANGIOPLASTY BALLOONS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL ANGIOPLASTY BALLOONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL STANDARD (SEMI-COMPLIANT) BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL STANDARD (SEMI-COMPLIANT) BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STANDARD (SEMI-COMPLIANT) BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NON-COMPLIANT BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-COMPLIANT BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NON-COMPLIANT BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CUTTING AND SCORING BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CUTTING AND SCORING BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CUTTING AND SCORING BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DRUG-COATED PERIPHERAL BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DRUG-COATED PERIPHERAL BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DRUG-COATED PERIPHERAL BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HIGH-PRESSURE PERIPHERAL BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIGH-PRESSURE PERIPHERAL BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HIGH-PRESSURE PERIPHERAL BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SPECIALTY PERIPHERAL BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SPECIALTY PERIPHERAL BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SPECIALTY PERIPHERAL BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROVASCULAR BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROVASCULAR BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROVASCULAR BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL REMODELING BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL REMODELING BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL REMODELING BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL OCCLUSION BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL OCCLUSION BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OCCLUSION BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NYLON BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NYLON BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NYLON BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL POLYURETHANE BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POLYURETHANE BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POLYURETHANE BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POLYETHYLENE TEREPHTHALATE BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POLYETHYLENE TEREPHTHALATE BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL POLYETHYLENE TEREPHTHALATE BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PEBAX BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PEBAX BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PEBAX BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SMALL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SMALL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SMALL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LARGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LARGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LARGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DISTRIBUTOR AND DEALER SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DISTRIBUTOR AND DEALER SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DISTRIBUTOR AND DEALER SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LARGE-SCALE DISTRIBUTOR NETWORKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LARGE-SCALE DISTRIBUTOR NETWORKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LARGE-SCALE DISTRIBUTOR NETWORKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INDEPENDENT DEALER NETWORKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INDEPENDENT DEALER NETWORKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INDEPENDENT DEALER NETWORKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ONLINE AND E-PROCUREMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ONLINE AND E-PROCUREMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ONLINE AND E-PROCUREMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CARDIAC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CARDIAC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 154. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 155. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 156. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 160. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 166. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 170. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 202. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 204. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 205. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 206. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 208. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 210. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 235. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 236. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 237. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 239. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 241. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 245. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 246. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 247. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 249. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 251. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 255. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 256. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 257. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 259. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 261. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 275. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 276. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 277. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 279. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 281. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 285. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 286. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 287. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 289. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 290. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 291. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 295. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 296. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 297. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 299. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 301. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 305. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 306. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 307. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 309. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 310. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 311. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 315. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 316. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 317. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 319. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 320. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 321. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 323. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 325. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 326. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 327. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 329. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 330. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
  • TABLE 331. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 332. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 333. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 334. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 335. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 336. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
  • TABLE 337. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 338. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
  • TABLE 339. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 340. BRAZIL ANGIOPLASTY BALLOONS